Back

Pulmonary hypertension in patients with heart failure with reduced ejection fraction: impact of the new definition of pulmonary hypertension

27 August 2023 (15:48 - 15:57)
Organised by: Logo
Congress Presentation Part of: Right and left heart disease: which comes first? Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Samuel Vysocansky

The National Institute of Cardiovascular Diseases, Bratislava (Slovakia)

4 More presentations in this session

Presentation thumbnail
Validation of the OPTICS and H2FPEF risk scores for post-capillary pulmonary hypertension in an asian cohort
Mr H. Jiang (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
PAH-specific treatment for patients with combined pre- and post-capillary pulmonary hypertension
Doctor T. Hofbauer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Risk assessment according to the presence of left heart disease phenotype in pulmonary arterial hypertension patients: a multicenter cohort study.
Doctor M. Toma (Genoa, IT)
Abstract Slides Video
Presentation thumbnail
Pulmonary hypertension associated with left heart disease among hospitalized patients: analysis of the Nationwide Inpatient Sample
Mr I. Farmakis (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Right and left heart disease: which comes first?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 15:48 CET
You may be interested in
thumbnail
Congress Presentation
The impact of the 2022 definition of pulmonary hypertension on long-term clinical outcomes in patients with heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Pulmonary hypertension due to left heart disease: first validation of the 2022 definitions in a prospective study, the PH-HF multicenter study
thumbnail
Congress Presentation
Impact of the 2022 ESC/ERS guidelines on diagnosing pulmonary hypertension in heart failure with reduced ejection fraction patients undergoing elective right heart catheterization

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources